Gaining In-Depth Insights into the US Market Landscape to Uncover Hidden Challenges & Anticipate Future Benefits for Strategic Decision-Making
Time: 4:00 pm
day: Conference Day One
Details:
- How to tackle patient enrolment hurdles such as co-pay concerns or fear to enhance treatment onboarding?
- Lessons learned about the barriers to utilization posing difficulties to broad access and utilization of cell and gene therapies as we prepare for more of these products to enter the market
- Assessing the potential value-based agreements, such as CMMI’s cell and gene therapy model in supporting increased access
